Challenges in Valuing and Paying for Combination Regimes in Oncology

11:00 AM - 12:00 PM, Wednesday, June 10, 2020 ・ Room 23C
Countries continue to grapple with pricing combination regimes in oncology, while ensuring timely patient access to these clinically important medicines. How can HTA agencies and payers provide fair value to these combination projects and deliver innovative combination regimes to patients? This session will highlight obstacles surrounding valuing combination products owned by separate companies.